A polyclonal anti-vaccine CD4 T cell response detected with HLA-DP4 multimers in a melanoma patient vaccinated with MAGE-3.DP4-peptide-pulsed dendritic cells

European Journal of Immunology

Volumn 35, Issue 4, 2005, Pages 1066-1075

  Zhang, Yi ^a   Renkvist, Nicolina ^a   Sun, Zhaojun ^a   Schuler Thurner, Beatrice ^b   Glaichenhaus, Nicolas ^c   Schuler, Gerold ^b   Boon, Thierry ^a   van der Bruggen, Pierre ^a   Colau, Didier ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c INSERM   (France)

Author keywords

CD4 T cell; Dendritic cell; HLA class II multimers; MAGE 3; Vaccine

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN GP 100; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA DP ANTIGEN; HLA DR4 ANTIGEN; MELANOMA ANTIGEN 3; MONOPHENOL MONOOXYGENASE; POLYMER; T LYMPHOCYTE RECEPTOR;

ADOPTIVE IMMUNOTHERAPY; ANTIGEN SPECIFICITY; ARTICLE; CANCER PATIENT; CASE REPORT; CELL SELECTION; CELLULAR IMMUNITY; CLONAL VARIATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DRUG DELIVERY SYSTEM; EX VIVO STUDY; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; MELANOMA; PERIPHERAL LYMPHOCYTE; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIBODIES, NEOPLASM; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; BIOTIN; CANCER VACCINES; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; EPITOPES, T-LYMPHOCYTE; HLA-DP ANTIGENS; HUMANS; IMMUNOTHERAPY, ADOPTIVE; MELANOMA; NEOPLASM PROTEINS; PEPTIDE FRAGMENTS; VACCINATION;

EID: 17444420354     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200425847     Document Type: Article

References (29)

1. Coulie, P. G., Karanikas, V., Colau, D., Lurquin, C., Landry, C., Marchand, M., Dorval, T., Brichard, V. and Boon, T., A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3. Proc. Natl. Acad. Sci. USA 2001. 98: 10290-10295.
2. Coulie, P. G., Karanikas, V., Lurquin, C., Colau, D., Connerotte, T., Hanagiri, T., Van Pel, A., Lucas, S., Godelaine, D., Lonchay, C. et al., Cytolytic T cell responses of cancer patients vaccinated with a MAGE antigen. Immunol. Rev. 2002. 188: 33-42.
3. Coulie, P. G. and van der Bruggen, P., T cell responses of vaccinated cancer patients. Curr. Opin. Immunol. 2003. 15: 131-137.
4. Lonchay, C., van der Brugged, P., Connerotte, T., Hanagiri, T., Coulie, P., Colau, D., Lucas, S., Van Pel, A., Thielemans, K., van Baren, N. and Boon, T., Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen. Proc. Natl. Acad. Sci. USA 2004. 101: 14631-14638.
5. Schuler-Thurner, B., Schultz, E. S., Berger, T. G., Weinlich, G., Ebner, S., Woerl, P., Bender, A., Feuerstein, B., Fritsch, P. O., Romani, N. and Schuler, G., Rapid induction of tumor-specific type I T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells. J. Exp. Med. 2002. 195: 1279-1288.
6. Phan, G. Q., Touloukian, C. E., Yang, J. C., Restifo, N. P., Sherry, R. M., Hwu, P., Topalian, S. L., Schwartzentruber, D. J., Seipp, C. A., Freezer, L. J. et al., Immunization of patients with metastatic melanoma using both class I- and class II-restricted peptides from melanoma-associated antigens. J. Immunother. 2003. 26: 349-356.
7. Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J. and Davis, M. M., Phenotypic analysis of antigen-specific T lymphocytes. Science 1996. 274: 94-96.
8. Day, C. L., Seth, N. P., Lucas, M., Appel, H., Gauthier, L., Lauer, G. M., Robbins, G. K., Szczepiorkowski, Z. M., Casson, D. R., Chung, R. T. et al., Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. J. Clin. Invest. 2003. 112: 831-842.
9. Meyer, A. L., Trollmo, C., Crawford, F., Marrack, P., Steere, A. C., Huber, B. T., Kappler, J. and Hafler, D. A., Direct enumeration of Borrelia-reactive CD4 T cells ex vivo by using MHC class II tetramers. Proc. Natl. Acad. Sci. USA 2000. 97: 11433-11438.
10. - T cell responses directed against influenza viral antigens postinfluenza vaccination. J. Immunol. 2003. 171: 3163-3169.
11. Lucas, M., Day, C. L., Wyer, J. R., Cunliffe, S. L., Loughry, A., McMichael, A. J. and Klenerman, P., Ex vivo phenotype and frequency of influenza virus-specific CD4 memory T cells. J. Virol. 2004. 78: 7284-7287.
12. Ye, M., Kasey, S., Khurana, S., Nguyen, N. T., Schubert, S., Nugent, C. T., Kuus-Reichel, K. and Hampl, J., MHC class II tetramers containing influenza hemagglutinin and EBV EBNA1 epitopes detect reliably specific CD4(+) T cells in healthy volunteers. Hum. Immunol. 2004. 65: 507-513.
13. Kwok, W. W., Liu, A. W., Novak, E. J., Gebe, J. A., Ettinger, R. A., Nepom, G. T., Reymond, S. N. and Koelle, D. M., HLA-DQ tetramers identify epitope-specific T cells in peripheral blood of herpes simplex virus type 2-infected individuals: direct detection of immunodominant antigen-responsive cells. J. Immunol. 2000. 164: 4244-4249.
14. Novak, E. J., Liu, A. W., Nepom, G. T. and Kwok, W. W., MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen. J. Clin. Invest. 1999. 104: R63-R67.
15. Lemaître, F., Viguier, M., Cho, M. S., Fourneau, J. M, Maillère, B., Kourilsky, P., van Endert, P. M. and Ferradini, L., Detection of low-frequency human antigen-specific CD4(+) T cells using MHC class II multimer bead sorting and immunoscope analysis. Eur. J. Immunol. 2004. 34: 2941-2949.
16. + cytolytic T lymphocytes. Cancer Res. 2000. 60: 6272-6275.
17. + T cells in resistant mice upon infection with Leishmania major. Immunity 2000. 13: 771-782.
18. Reichstetter, S., Ettinger, R. A., Liu, A. W., Gebe, J. A., Nepom, G. T. and Kwok, W. W., Distinct T cell interactions with HLA class II tetramers characterize a spectrum of TCR affinities in the human antigen-specific T cell response. J. Immunol. 2000. 165: 6994-6998.
19. Schultz, E. S., Schuler-Thurner, B., Stroobant, V., Jenne, L., Berger, T. G., Thielemans, K., van der Bruggen, P. and Schuler, G., Functional analysis of tumor-specific Th cell responses detected in melanoma patients after dendritic cell-based immunotherapy. J. Immunol. 2004. 172: 1304-1310.
20. + regulatory T cells and their ligands: implications for immunotherapy. Immunity 2004. 20: 107-118.
21. Godelaine, D., Carrasco, J., Lucas, S., Karanikas, V., Schuler-Thurner, B., Coulie, P. G., Schuler, G., Boon, T. and Van Pel, A., Polyclonal CTL responses observed in melanoma patients vaccinated with dendritic cells pulsed with a MAGE-3.A1 peptide. J. Immunol. 2003. 171: 4893-4897.
22. Karanikas, V., Lurquin, C., Colau, D., van Baren, N., De Smet, C., Lethé, B., Connerotte, T., Corbière, V., Demoitié, M.-A., Liénard, D. et al., Monoclonal anti-MAGE-3 CTL responses in melanoma patients displaying tumor regression after vaccination with a recombinant canarypox virus. J. Immunol. 2003. 171: 4898-4904.
23. + T cells that were isolated from a melanoma patient vaccinated with a MAGE-3 protein. J. Immunol. 2003. 171: 219-225.
24. Thurner, B., Haendle, I., Roder, C., Dieckmann, D., Keikavoussi, P., Jonuleit, H., Bender, A., Maczek, C., Schreiner, D., von den Driesch, P. et al., Vaccination with MAGE-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J. Exp. Med. 1999. 190: 1669-1678.
25. + melanoma patients by mature monocyte-derived dendritic cells. J. Immunol. 2000. 165: 3492-3496.
26. Scott, C. A., Garcia, K. C., Stura, E. A., Peterson, P. A., Wilson, I. A. and Teyton, L., Engineering protein for X-ray crystallography: the murine major histocompatibility complex class II molecule I-Ad. Protein Sci. 1998. 7: 413-418.
27. Scott, C. A., Garcia, K. C., Carbone, F. R., Wilson, I. A. and Teyton, L., Role of chain pairing for the production of functional soluble IA major histocompatibility complex class II molecules. J. Exp. Med. 1996. 183: 2087-2095.
28. Bunch, T. A., Grinblat, Y. and Goldstein, L. S., Characterization and use of the Drosophila metallothionein promoter in cultured Drosophila melanogaster cells. Nucleic Acids Res. 1988. 16: 1043-1061.
29. Genevée, C., Diu, A., Nierat, J., Caignard, A., Dietrich, P. Y., Ferradini, L., Roman-Roman, S., Triebel, F. and Hercend, T., An experimentally validated panel of subfamily-specific oligonucleotide primers (Vα1-w29/Vβ1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction. Eur. J. Immunol. 1992. 22: 1261-1269.